CAM
ABBV icon

Connacht Asset Management’s AbbVie ABBV Stock Holding History

Connacht Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,366
Closed -$1.39M – 113
2022
Q3 		$1.39M Sell
10,366
-1,619
-14% -$232K 0.99% 25
2022
Q2 		$1.84M Buy
11,985
+4,621
+63% +$706K 0.77% 23
2022
Q1 		$1.19M Buy
+7,364
New +$1.07M 0.61% 47

Other funds holding ABBV

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Connacht Asset Management's ABBV Position: Q4 2022 in Review

Connacht Asset Management sold out of AbbVie (ABBV) in Q4 2022, closing a stake of 10,366 shares — an estimated $1.39M sold.

Connacht Asset Management first reported a position in ABBV in Q1 2022 and held it in 3 quarters. The position peaked at $1.84M in Q2 2022. 3,168 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

  • Connacht Asset Management reported no remaining AbbVie position as of Q4 2022 after selling out during the quarter.
  • Connacht Asset Management sold 10,366 AbbVie shares in Q4 2022, an estimated $1.39M.
  • Connacht Asset Management first reported a position in AbbVie in Q1 2022 and held it in 3 quarters.
  • Connacht Asset Management's AbbVie position peaked at $1.84M in Q2 2022.
  • 3,168 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Connacht Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.